EBV (EBNA-3A) Peptide Pool, STEMCELL Technologies (CAT#: STEM-CT-0823-ZJF)

Stimulating T cells with EBV (EBNA-3A) Peptide Pool releases downstream cytokines and upregulates activation markers, enabling antigen-specific T cells to be detected or isolated for analysis. EBV (EBNA-3A) Peptide Pool is a lyophilized mixture of 234 peptides from Epstein-Barr nuclear antigen 3 (EBNA-3A) of Epstein-Barr virus (EBV; strain B95-8) and consists of 15-mer peptides with 11-amino-acid overlaps that cover amino acids 1 - 944 on EBNA-3A. EBNA-3A contributes to B cell growth transformation (Hertle et al.; Tomkinson et al.) and has been found to interact with host cell proteins, where it activates (Young et al.) or represses (Cludts & Farrell; Hickabottom et al.) transcription of specific cellular genes. Viral peptide pools are useful for a broad range of applications, including vaccine development, immunological research, and diagnostic assay development.

Subtype: Peptide Pools
Species: Other
Application: Activation, Cell Culture
Area of Interest: Infectious Diseases
Purity: Average 70%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

EBV (LMP1) Peptide Pool, STEMCELL Technologies
EBV (EBNA-3B) Peptide Pool, STEMCELL Technologies
HIV-1 (B Gag) Peptide Pool, STEMCELL Technologies
HIV (HLA Class I Control) Peptide Pool, STEMCELL Technologies